179 related articles for article (PubMed ID: 3495799)
1. Interleukin 4 is a growth factor for activated thymocytes: possible role in T-cell ontogeny.
Zlotnik A; Ransom J; Frank G; Fischer M; Howard M
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3856-60. PubMed ID: 3495799
[TBL] [Abstract][Full Text] [Related]
2. Early precursor thymocytes can produce interleukin 2 upon stimulation with calcium ionophore and phorbol ester.
Lugo JP; Krishnan SN; Sailor RD; Rothenberg EV
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1862-6. PubMed ID: 3081905
[TBL] [Abstract][Full Text] [Related]
3. Thymic stroma-derived T cell growth factor (TSTGF). IV. Capacity of TSTGF to promote the growth of L3T4- Lyt-2- thymocytes by synergy with phorbol myristate acetate or various IL.
Mizushima Y; Saitoh M; Ogata M; Kosaka H; Tatsumi Y; Kiyotaki C; Hamaoka T; Fujiwara H
J Immunol; 1989 Feb; 142(4):1195-202. PubMed ID: 2783707
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes.
Ransom J; Fischer M; Mosmann T; Yokota T; DeLuca D; Schumacher J; Zlotnik A
J Immunol; 1987 Dec; 139(12):4102-8. PubMed ID: 3121729
[TBL] [Abstract][Full Text] [Related]
5. Proliferation in vitro of Lyt2-,L3T4- thymocytes shows responsiveness to interleukin 1.
Chaudhri G; Clark IA; Ceredig R
Clin Exp Immunol; 1988 Jul; 73(1):51-6. PubMed ID: 3262467
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements.
Howe RC; MacDonald HR
J Immunol; 1988 Feb; 140(4):1047-55. PubMed ID: 3257768
[TBL] [Abstract][Full Text] [Related]
7. Analysis of isolated and combined effects of calcium ionophore and phorbol ester on T lymphocyte activation.
Nóbrega AF; Maldonado MS; Dos Reis GA
Clin Exp Immunol; 1986 Sep; 65(3):559-69. PubMed ID: 3096619
[TBL] [Abstract][Full Text] [Related]
8. The mode of action of the calcium ionophore A23187 on T cell proliferation. I. The ionophore does not replace lymphokines but acts via induction of IL-2 production on IL-2 responsive cells.
Josimovits O; Osawa H; Diamantstein T
Immunobiology; 1985 Sep; 170(3):164-74. PubMed ID: 3932189
[TBL] [Abstract][Full Text] [Related]
9. Proliferation in vitro and interleukin production by 14 day fetal and adult Lyt-2-/L3T4- mouse thymocytes.
Ceredig R
J Immunol; 1986 Oct; 137(7):2260-7. PubMed ID: 3093570
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interleukin 4/BSF-1 promotes growth and differentiation of intrathymic T cell precursors from fetal mice in vitro.
Palacios R; Sideras P; von Boehmer H
EMBO J; 1987 Jan; 6(1):91-5. PubMed ID: 3495433
[TBL] [Abstract][Full Text] [Related]
11. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
12. Selective down modulation of L3T4 molecules on murine thymocytes by the tumor promoter, phorbol 12-myristate 13-acetate.
Wang PT; Bigby M; Sy MS
J Immunol; 1987 Oct; 139(7):2157-65. PubMed ID: 3498751
[TBL] [Abstract][Full Text] [Related]
13. Identification of IL-6 as a T cell-derived factor that enhances the proliferative response of thymocytes to IL-4 and phorbol myristate acetate.
Hodgkin PD; Bond MW; O'Garra A; Frank G; Lee F; Coffman RL; Zlotnik A; Howard M
J Immunol; 1988 Jul; 141(1):151-7. PubMed ID: 2967865
[TBL] [Abstract][Full Text] [Related]
14. Antigen-independent activation of cytotoxic T cells by lymphokines.
Williams LD; McMaster WR; Teh HS
Immunology; 1988 May; 64(1):121-8. PubMed ID: 3133307
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interleukin 4 promotes the growth of human T cells.
Spits H; Yssel H; Takebe Y; Arai N; Yokota T; Lee F; Arai K; Banchereau J; de Vries JE
J Immunol; 1987 Aug; 139(4):1142-7. PubMed ID: 3497196
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
Ransom J; Fischer M; Mercer L; Zlotnik A
J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic effect of PMA + IL 2 on subpopulations of corticoresistant thymocytes.
Dupuy d'Angeac A; Monis M; Rème T
J Immunol; 1986 Dec; 137(11):3501-8. PubMed ID: 3097124
[TBL] [Abstract][Full Text] [Related]
18. B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes.
Hu-Li J; Shevach EM; Mizuguchi J; Ohara J; Mosmann T; Paul WE
J Exp Med; 1987 Jan; 165(1):157-72. PubMed ID: 3098893
[TBL] [Abstract][Full Text] [Related]
19. Functional status of interleukin 2 receptors expressed by immature (Lyt-2-/L3T4-) thymocytes.
Lowenthal JW; Howe RC; Ceredig R; MacDonald HR
J Immunol; 1986 Oct; 137(8):2579-84. PubMed ID: 3093578
[TBL] [Abstract][Full Text] [Related]
20. Thymic lymphocytes. III. Cooperative phenomenon in the proliferation of thymocytes under Con A stimulation.
Papiernik M; Jacobson JB
Cell Immunol; 1986 Jan; 97(1):23-33. PubMed ID: 3091269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
